Skip to main content
Infant Formula Recall Retirada del mercado de fórmula infantil

ALERT: ByHeart Recalls Whole Nutrition Infant Formula. Read more

AVISO IMPORTANTE: ByHeart retira del mercado su fórmula infantil Whole Nutrition. Aprender más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

New Texas Medicaid Genetic Testing Policy for October 2025

Date: October 7, 2025

Attention: Providers

Effective date: October 1, 2025

Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that the Health and Human Services Commission (HHSC) has created an overarching policy for genetic testing benefits for Texas Medicaid clients. The new Genetic Testing policy language can be found in the Radiology and Laboratory Services Handbook in the Texas Medicaid Provider Procedures Manual effective October 1, 2025.

Please note that existing standalone genetic testing policies such as the Breast Cancer Gene 1 and 2 (BRCA) Testing, Cytogenetics Testing, Noninvasive Prenatal Screening (NIPS), etc. will continue to remain discrete and distinct policies.

How this impacts providers:

More information on the new policy is as follows.

  • The new Genetic Testing Medicaid policy establishes general overarching policy language for fee-for-service genetic testing benefits where standard benefit statements including medical necessity, prior authorization, restriction/limitation, billing, documentation, claim processing, etc. are located.
  • This policy also captures certain existing genetic testing benefits that are currently listed only in the Texas Medicaid fee schedule but are without existing benefit language.
  • This policy does not add new benefit coverage.
  • This policy will serve as a general location for future genetic testing benefit language that may not require an independent policy.

Next step for Providers: Providers should share this communication with their staff.

If you have any questions, please email Provider Relations at providerrelations@texaschildrens.org

For access to all provider alerts: www.texaschildrenshealthplan.org/provideralerts.